insights_auto
Why is INO down 3.97%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.45
arrow_downward
-3.97%(-0.060) 1D
$1.32
arrow_downward
-8.97% (-0.13)todayPre-market
Closed: Nov 10, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.48
High
$1.51
Low
$1.40
Mkt. cap
244.95M
Avg. vol.
18.40M
Volume
152.75K
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
Open
$1.48
High
$1.51
Low
$1.40
Mkt. cap
244.95M
Avg. vol.
18.40M
Volume
152.75K
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
GuruFocus
·
6 hours ago
FMR LLC Adds Inovio Pharmaceuticals Inc (INO) Shares -- Stock Looks 625% Overvalued on GF Value
TradingView
·
7 hours ago
Inovio Pharmaceuticals Q3 2026 Earnings Call Is Live
Yahoo Finance
·
8 hours ago
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Investing.com India
·
10 hours ago
Inovio Q3 2026 slides: VOCERYQ approval amid wider loss By Investing.com
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com